Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: ROCHE MOLECULAR SYSTEMS INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-05-02 to 2024-05-01
Current total value of award: $22624000
Description: THE PURPOSE OF THIS MODIFICATION IS TO UPDATE THE PROGRAM ACRONYM TO READ RADX AND SEC TO B4.